PRISM: Molecular phenotyping of severe asthma patients to determine response to biologic therapies
We will shortly be commencing this important collaborative asthma research funded by a £2.3 million grant from the Medical Research...
PRISM: Molecular phenotyping of severe asthma patients to determine response to biologic therapies
CF STORM a ground-breaking trial to assess management of CF patients daily healthcare routines
More positive results from #ANDHI study for Benralizumab in Severe Eosinophilic Asthma
SPRINTER Study a Phase 3 trial of SNG001 in patients hospitalised with Covid-19
A year ago today NUH recruited their 1st patient into the worlds biggest #Covid19 treatment trial
Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
APEX Asthma Exacerbation Studies Newsletter
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease